Asst. Prof. Dr. TAYFUN GARİP

Endocrinology and Metabolism

Medipol University Pendik Hospital
TAYFUN GARİP

Birthplace

ZONGULDAK

Medical Areas of Interest

  • Thyroid and Parathyroid Diseases
  •   Diabetes Diagnosis and Monitoring
  •   Hormonal Disorders During Pregnancy
  •   Pituitary Diseases
  •   Obesity
  •   Adrenal Gland Diseases

Experiences

2020

Istanbul Medipol University Pendik Hospital

2018 - 2020

VM Medical Park Pendik Hospital

2013 - 2018

Emsey Hospital

2013 - 2013

Derince Training and Research Hospital

2011 - 2013

Sakarya Training and Research Hospital

2006 - 2010

Kocaeli University Faculty of Medicine

2006 - 2006

Merkez Hospital, Gebze

2005 - 2006

Taşova State Hospital

2004 - 2005

Turkish Naval Forces Command, Karadeniz Ereğli Infirmary

2003 - 2003

Taşova State Hospital

1998 - 2003

Haydarpaşa Numune Hospital

Educations

2010

Kocaeli University Faculty of Medicine, Endocrinology and Metabolic Diseases

2003

Haydarpaşa Numune Hospital, Internal Medicine

1998

Erciyes University, Faculty of Medicine

Publications

A. Articles published in internationally refereed journals:

A1. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.

Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. J Diabetes Complications. 2009 Mar-Apr;23 (2):89-94. Doi:10.1016/j.jdiacomp.2008.01.006. Epub 2008 Mar 20. PMID:18358749

A2. Hypokalemia-induced myopathy and massive creatine elevation as first manifestation of Conn’s syndrome. Olt S, Yaylaci S, Tatli L, Gunduz Y, Garip T, Tamer A. Niger Med J. 2013 Jul;54 (4):283-4. Doi: 10.4103/0300-1652.119558. PMID:24249961

A3. A Case of QT Prolongation Associated with Panhypopituitarism.

Arpaci D, Demir MV, Garip T, Tamer A.

Case Rep Endocrinol. 2013;2013:989745. doi: 10.1155/2013/989745. Epub 2013 May 9.

PMID: 23762665

A4. ‘Graves’ disease: A rare cause of cholestasis.

Ahmet Tarık Eminler, Serdar Olt, Mustafa Ihsan Uslan, Orhan Veli Ozkan, Selcuk Yaylaci, Tayfun Garip, Fehmi Celebi.

Thyroid Research & Practice.2014, volume:11, Issue:2, Page:76-77.

A5. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N. Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016. PMID: 27274207

A6. Assessment of attainment of recommended TSH levels and levothyroxine compliance in

differentiated thyroid cancer patients.

Dilek Goga Yavuz, Ceyda d. Yazan, Zeliha Hekimsoy, Kadriye Aydın, Naile Gökkaya, Canan Ersoy,

Aysen Akalın, Omercan Topaloğlu, Berna I. Aydoğan, Esra N.A Dilekci, Ziynet Alphan Uc, Güven B.

Cansu, Levent Ozsarı, Ozlem T. Iyidir, Mehtap E. Olgun, Lezzan Keskin, Meral Mert, Bulent Can,

Kaan Gungor, Tayfun Galip, Zeynep Cantürk, Gulsah Elbuken, Zafer Pekkolay, Nilufer o. Kutbay,

Goknur Yorulmaz, Ahmet T. Kalkan, Yasemin A. Unsal, Adnan Yay, Baris Karagun, Evin Bozkur.

Clinical Endocrinology. 31 May 2022. doi.org/10.1111/cen.14787.

B. Papers presented at international scientific meetings and published in proceedings:

B1. Research on the Frequency of Malignancy of Hypoactive Thyroid Nodules Seen in Patients with Graves by using Fine-Needle Aspiration Biopsy. EANM’14-Annual Congress of the European Association of Nuclear Medicine October 18-22, 2014.

C. National/international books written or chapters in books:

C1. National/international books written:

C1.1. Translation of the Female Reproductive Endocrinology and Infertility chapter (Chapter 14) of the Turkish translation of the 8th Edition of Greenspan's Basic and Clinical Endocrinology.

C2. Chapters in national/international books written:

C2.1. Authorship of the chapter on Diabetes and Cancer (Chapter 58) in the book Diabetes Mellitus from the Past to the Future-2015.

C2. Chapters in national/international books written:

C3.1. Authorship of the chapter on Medullary Thyroid Cancer (Chapter 23) in the book Multidisciplinary Approach to Thyroid Diseases-2019.

D. Articles published in national refereed journals:

D1. ……………………………………………………………………………………………………………………………………..

E. Papers presented at national scientific meetings and published in proceedings:

E1. Investigation of Malignancy Frequency with Fine-Needle Aspiration Biopsy in Hypoactive Nodules Monitored in Graves' Patients. 26th National Congress of Nuclear Medicine April 16-20, 2014.

E2. Simultaneous Medullary and Papillary Thyroid Carcinoma and V-DMSA Uptake. 25th National Congress of Nuclear Medicine April 6-10, 2013.

E3. Prevalence of Cyclin-D1 and RET/PTC Expression in Papillary Thyroid Cancer and Its Relationship with Prognostic Factors. 5th Turkey Thyroid Diseases Congress-2012. (Oral Presentation)

E4. Thyroid Gland Hemiagenesis: Three Case Reports. 36th Turkey Endocrinology and Metabolic Diseases Congress. 21-25 May 2014.

E5. A Case of QT Prolongation Associated with Panhypopituitarism. 35th Turkey Endocrinology and Metabolic Diseases Congress. 15-19 April 2013.

E6. A Case of Hyponatremic-Hypertensive Syndrome Presenting with Hypertension, Hypokalemia and Adrenal Mass. 30th Turkey Endocrinology and Metabolic Diseases Congress.

E7. A Case of Papillary Microcarcinoma Presenting with Widespread Cervical Lymph Node Metastasis. 30th Turkey Endocrinology and Metabolic Diseases Congress.

E8. A Case of Langerhans Cell Histiocytosis Diagnosed in Adulthood. 31st Turkey Endocrinology and Metabolic Diseases Congress.

E9. A Case Presenting with Hypertensive Attack Diagnosed with Neurofibromatosis and Pheochromocytoma. 31st Turkey Endocrinology and Metabolic Diseases Congress.

E10. A Case Report of Fahr Syndrome. 31st Turkey Endocrinology and Metabolic Diseases Congress.

E11. Ectopic Parathyroid Adenoma in an Unusual Location. 31st Turkey Endocrinology and Metabolic Diseases Congress.

F. Art and design activities:

F1. ……………………………………………………………………………………………………………………………………..

G. Other publications:

(All works that are intended to be specified but do not fall into the categories under the headings above will be listed under this item.)

G1. Adrenal Incidentalomas, Haydarpaşa Numune Training and Research Hospital Medical Journal, 2004,

G2. Evaluation of the Oral Glucose Tolerance Test in Nonalcoholic Fatty Liver Disease, Haydarpaşa Numune Training and Research Hospital Medical Journal, 2003,

G3. The Effect of a Mixture of 75% Insulin Lispro Protamine Suspension and 25% Insulin Lispro Injection on Diabetes Regulation, Haydarpaşa Numune Training and Research Hospital Medical Journal, 2003.

G4. Cushing's Syndrome. 2012 Endocrine Cases Journal

Memberships

  •  Turkish Endocrinology and Metabolism Diseases
  •  Turkish Medical Association

Areas of Expertise

  •  Endocrinology and Metabolic Diseases

Scientific Activities

"The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. 

 Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. 

 J Diabetes Complications. 2009 Mar-Apr;23 (2):89-94. 

 Doi:10.1016/j.jdiacomp.2008.01.006. Epub 2008 Mar 20. PMID:18358749 Hypokalemia-induced myopathy and massive creatine elevation as first manifestation of 

 Conn’s syndrome. 

 Olt S, Yaylaci S, Tatli L, Gunduz Y, Garip T, Tamer A. Niger Med J. 2013 Jul;54 (4):283-4. Doi: 10.4103/0300-1652.119558. PMID:24249961 

  A Case of QT Prolongation Associated with Panhypopituitarism. 

 Arpaci D, Demir MV, Garip T, Tamer A. 

 Case Rep Endocrinol. 2013;2013:989745. doi: 10.1155/2013/989745. Epub 2013 May 9. 

 PMID: 23762665 

  ‘Graves’ disease: A rare cause of cholestasis. 

 Ahmet Tarık Eminler, Serdar Olt, Mustafa Ihsan Uslan, Orhan Veli Ozkan, Selcuk Yaylaci, Tayfun Garip, Fehmi Celebi. 

 Thyroid Research & Practice.2014, volüm:11, Issue:2, Page:76-77. 

  Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N. 

 Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016. PMID: 27274207 

 Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients 

 Dilek Gogas Yavuz , Ceyda D Yazan , Zeliha Hekimsoy , Kadriye Aydin , Naile 

 Gokkaya , Canan Ersoy , Aysen Akalın , Omercan Topaloglu , Berna I Aydogan , Esra N A 

 Dilekci , Ziynet Alphan Uc , Guven B Cansu , Levent Ozsari , Ozlem T Iyidir , Mehtap E 

 Olgun , Lezzan Keskin , Meral Mert , Bulent Can , Kaan Gungor , Tayfun Galip , Zeynep 

 Cantürk , Gulsah Elbuken , Zafer Pekkolay , Nilufer O Kutbay , Goknur Yorulmaz , Ahmet T 

 Kalkan , Yasemin A Unsal , Adnan Yay , Baris Karagun , Evin Bozkur 

 Clin Endocrinol (Oxf) 2022 Dec;97(6):833-840. doi: 10.1111/cen.14787. Epub 2022 Jun 12. 

 . This is the Turkish translation of the section on female reproductive endocrinology and infertility (Chapter 14) from the 8th edition of Greenspan's Basic and Clinical Endocrinology. . 

 Authorship of the chapter on Diabetes and Cancer (Chapter 58) in the book Diabetes Mellitus from Past to Future - 2015. . 

 Authorship of the chapter on Medullary Thyroid Cancer (Chapter 23) in the book ""Multidisciplinary Approach to Thyroid Diseases - 2019"". .. 

 Papers presented at national scientific meetings and published in proceedings: 

 Investigation of Malignancy Frequency in Hypoactive Nodules Observed in Graves' Disease Patients Using Fine Needle Aspiration Biopsy. 26. National Nuclear Medicine Congress, April 16-20, 2014. 

 Simultaneous Medullary and Papillary Thyroid Carcinoma and V-DMSA Involvement. 25. National Nuclear Medicine Congress, April 6-10, 2013. 

 Prevalence of Cyclin-D1 and RET/PTC Expression in Papillary Thyroid Cancer and its Relationship with Prognostic Factors. . 5th Turkish Thyroid Diseases Congress - 2012. (Verbal Presentation)

  Thyroid Gland Hemiagenesis: Three Case Presentations. 36. Turkish Congress of Endocrinology and Metabolic Diseases. May 21-25, 2014. 

 A Case of QT Prolongation Associated with Panhypopituitarism. 35. Turkish Congress of Endocrinology and Metabolic Diseases. April 15-19, 2013. 

 A Case of Hyponatremic Hypertensive Syndrome Presenting with Hypertension, Hypokalemia, and Adrenal Mass. 30. Turkish Congress of Endocrinology and Metabolic Diseases.

 A Case of Papillary Microcarcinoma Presenting with Widespread Cervical Lymph Node Metastasis. 30. Turkish Congress of Endocrinology and Metabolic Diseases. 

 A Case of Langerhans Cell Histiocytosis Diagnosed in Adulthood. 31st Turkish Congress of Endocrinology and Metabolic Diseases. 

 A Case Presenting with Hypertensive Attack and Diagnosed with Neurofibromatosis and Pheochromocytoma. 31st Turkish Congress of Endocrinology and Metabolic Diseases. 

 Fahr Syndrome Case Presentation. 31st Turkish Congress of Endocrinology and Metabolic Diseases. 

 Ectopic parathyroid adenoma with an unusual location. 31st Turkish Congress of Endocrinology and Metabolic Diseases. 

 Other Publications

  Adrenal Incidentalomas, Haydarpaşa Sample Training and Research Hospital Medical Journal, 2004,

 Evaluation of Oral Glucose Tolerance Test in Non-Alcoholic Fatty Liver Disease,

  Haydarpaşa Sample Training and Research Hospital Medical Journal, 2003, 75% Insulin Lispro Protamine Suspension and 25% Insulin Lispro Injection

  The Effect of the Mixture on Diabetes Regulation, Haydarpaşa Sample Training and Research Hospital Medical Journal, 2003. 

  Cushing Syndrome. 2012 Journal of Endocrine Cases

Additional Information

Phase III, randomized, active-controlled (Pioglitazone) clinical study investigating the efficacy and safety of MK-0431A (a fixed-dose combination tablet containing Sitagliptin and Metformin) in patients with Type 2 Diabetes Mellitus (as Sub-Investigator).

A 26-week, randomized, open-label, two-arm, parallel-group, treat-to-target clinical study (NN5401-3592) comparing the efficacy and safety of twice-daily soluble insulin analogue combination (SIAC) therapy, administered alone or in combination with metformin, DPP-4 inhibitor, and pioglitazone, versus twice-daily biphasic insulin aspart 30 (BIAsp) therapy in volunteers with Type 2 Diabetes Mellitus who failed to achieve adequate glycemic control with oral antidiabetic drugs (OADs) alone or in combination with once- or twice-daily premixed insulin or patient-prepared mixed insulin regimens (as Sub-Investigator).

NN-1849 Treat-to-Target Titration Study with Biphasic Insulin Aspart 30: A study evaluating the efficacy and safety of biphasic insulin aspart 30 in patients with Type 2 Diabetes Mellitus who have not achieved glycemic targets with oral antidiabetic drugs (OADs), either alone or in combination with once-daily basal insulin therapy (as Sub-Investigator).